Mineralys Therapeutics, Inc. - COMMON STOCK (MLYS)

CUSIP: 603170101

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+132,754
Put/Call ratio
58%
SEC-reported price per share
$12.11
Number of holders
105
Value change
+$2,379,010
Number of buys
54
Open additional details 1 more signal available
Number of sells
28
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
87,484,107

Security key

603170101

Report period

Q3 2024

Institutions

105

Top holders

10

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
Catalys Pacific, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $107,576,574 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Catalys Pacific, LLC has the largest disclosed position value at $107.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Catalys Pacific, LLC's linked filing trail.
Disclosed position value Top 5
HBM Healthcare Investments (Cayma... $19.2M
Catalys Pacific, LLC $107.58M
Samsara BioCapital, LLC $59.38M
RA CAPITAL MANAGEMENT, L.P. $56.76M
TCG Crossover Management, LLC $37.27M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HBM Healthcare Investments (Cayman) Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$19,199,542
3,218,106 shares
— 14 Feb 2023
Catalys Pacific, LLC
13F
Company
13F
—
denominator unverified
$107,576,574
9,194,579 shares
— 30 Jun 2024
Samsara BioCapital, LLC
13F
Company
13F
—
denominator unverified
$59,376,517
5,074,916 shares
— 30 Jun 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$56,756,513
4,850,984 shares
— 30 Jun 2024
TCG Crossover Management, LLC
13F
Company
13F
—
denominator unverified
$37,266,665
3,185,185 shares
— 30 Jun 2024
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$23,934,713
2,045,702 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
105
Shares
44,382,325
Rows available
105
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
93
Q3 2024 holders
105
Holder diff
12
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .